Amlodipina

Norvasc, Giant, Bivis e altri

1. Abernethy D.R., Am. Heart J., 1989, 118, 1100.

2. Australian Adverse Drug Reaction Bulletin, 2002, 21, 14.

3. Baker B.A., Cacchione J.G., Ann. Pharmacother., 1994, 28, 118.

4. Burges R.A. et al., Am. J. Cardiol., 1989, 10.

5. Burris J.F. et al., Am. J. Cardiol., 1994, 73 Suppl., 39A.

6. Collins P., Ferguson J., Br. J. Dermatol., 1993, 129, 630.

7. Dacosta A. et al., Therapie, 1994, 49, 515.

8. Dahlof B. et al., Lancet, 2005, 366 (9489), 895 (studio Ascot-Bpla)

9. de Bruijn B. et al., J. Cardiovasc. Pharmacol., 1988, 12 (Suppl. 7), S107.

10. Faulkner J.K. et al., Br. J. Clin. Pharmacol., 1986, 22, 21.

11. Fleckenstein A. et al., Am. J. Cardiol., 1989, 21.

12. Fogari R. et al., Am. J. Hypertension, 2002, 15, 1042.

13. Frick M.H. et al., J. Cardiovasc. Pharmacol., 1988, 12 (Suppl. 7), S76.

14. Hernàndez R. et al., Clin. Ther., 1993, 15, 304.

15. JAMA, 2002, 288, 2981 (Studio ALLHAT).

16. Julius S., J. Cardiovac. Pharmacol., 1988, 12 (Suppl.7), S27.

17. Julius S. et al., Lancet, 2004, 363 (9426), 2022.

18. Lancet, 2000, 356, 366.

19. Licata G. et al., Eur. J. Clin. Pharmacol., 1993, 45 (4), 307.

20. Lim A.C. et al., Australasian J. Dermatol., 2002, 43, 24.

21. Lorimer A.R. et al., J. Cardiovasc. Pharmacol., 1988, S89.

22. Lund-Johansen P. et al., J. Hypertens., 1990, 8, 1129.

23. Matthes J. et al., Naunyn-Schmiedeberg's Arch. Pharmacol., 2000, 361, 578.

24. Nayler W.G., Am. J. Med., 1991, 90, 8S.

25. Osterloh I., Am. Heart J., 1989, 118, 1114.

26. Pahor M. et al., Diabetes Care, 2000, 23, 888.

27. Philipp T. et al., Clin. Ther., 2007, 29, 563.

28. Poldermans D. et al., Clin. Ther., 2007, 29, 279.

29. Preston R.A. et al., Am. Soc. Hypertens. Sci. Meet., 2004, 22 maggio, New York.

30. Reid J.L. et al., J. Cardiovasc. Pharmacol., 1988, 12 (Suppl.7), S22.

31. Rofman B.A., J. Cardiovasc. Pharmacol., 1989, S94.

32. Sempere A.P. et al., Mov. Disord., 1995, 10, 115.

33. Stopher D.A. et al., J. Cardiovasc. Pharmacol., S55.

34. Tatti P. et al. Diabetes Care, 1998, 21, 597 (studio FACET).

35. Taylor S.H., Am. Heart J., 1989, 118, 1123.

36. Udelson J.E. et al., Am. Heart J., 2000; 139 (3), 503.

37. Webster J. et al., J. Cardiovasc. Pharmacol., 1988 12 (Suppl.7), S72.